Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 210
interventional 129
Observational 76
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 47
Biological 12
Other 12
Procedure 12
Behavioral 5
Drug|placebo 5
Drug|Procedure 5
Drug|Procedure|Radiation 5
Biological|Drug|Radiation 4
Device 4
Device|Drug 3
Biological|Drug 2
Diagnostic Test 2
Dietary Supplement 2
Other|Procedure 2
Behavioral|Device|Drug|Other|placebo 1
Biological|Device 1
Biological|Drug|Other|Procedure|Radiation 1
Biological|Drug|Procedure|Radiation 1
Combination Product 1
Drug|Other 1
Genetic 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 57
NA 16
France 11
Canada 4
Belgium 3
China 3
Denmark 3
Germany 2
Japan 2
Korea, Republic of 2
United States|Canada 2
Australia|Belgium|Canada|Denmark|France|Germany|Ireland|Italy|Netherlands|Spain|United Kingdom 1
Austria|Belgium|China|Germany|Hong Kong|Italy|Netherlands|Portugal|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
Belgium|France|Netherlands 1
Czechia 1
Egypt 1
France|South Africa|United Kingdom 1
France|United States|Canada 1
India|Korea, Republic of|Thailand 1
Indonesia|Korea, Republic of|Philippines|Thailand 1
Iran, Islamic Republic of 1
Israel 1
Italy 1
Qatar 1
Russian Federation 1
Saudi Arabia 1
Singapore 1
United States|Australia|Austria|Canada|Chile|Czechia|Denmark|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Poland|Portugal|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Australia|Finland|France|Germany|Netherlands|Spain|United Kingdom 1
United States|Belgium|Canada|Germany|Italy 1
United States|Canada|Germany|Italy|United Kingdom 1
United States|France|Hungary|Italy|Japan|Korea, Republic of|Malaysia|Netherlands|Russian Federation|Spain|Thailand|Turkey|United Kingdom 1
United States|France|Italy|Spain|United Kingdom 1
United States|Germany|Netherlands 1
United States|Norway 1

Sites per Study

Site_count Study_Count
1 96
2 4
3 2
4 4
5 1
6 2
7 2
8 2
9 1
11 3
12 2
14 2
15 1
16 1
18 1
22 1
36 1
45 1
52 1
59 1

Phase

Phase Study_Count
N/A 42
Phase 2 33
Phase 3 19
Phase 1/Phase 2 13
Phase 1 11
Phase 4 8
Phase 2/Phase 3 2
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 46
2 44
3 6
4 5
5 2
6 1
7 1
NA 24

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 20 10.0000 12.00000 10.00000 4.00000 22.0 12.0000 20.0
1st Qu. 20 30.0000 22.00000 30.00000 28.00000 166.5 46.7500 30.0
Median 20 50.0000 24.00000 45.00000 56.00000 311.0 81.0000 35.0
Mean 20 127.3659 55.81818 82.07692 70.62963 311.0 280.4167 187.5
3rd Qu. 20 138.0000 40.00000 64.00000 96.00000 455.5 203.7500 112.5
Max. 20 960.0000 235.00000 500.00000 213.00000 600.0 2016.0000 1100.0

Trial Group Type

group_type Group_Count
Experimental 125
Active Comparator 34
NA 24
Other 22
No Intervention 7
Placebo Comparator 7

Intervention Model

intervention_model Study_Count
Parallel Assignment 54
Single Group Assignment 51
NA 18
Crossover Assignment 4
Factorial Assignment 1
Sequential Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 87
Prevention 15
Supportive Care 13
Other 5
Basic Science 3
Diagnostic 2
NA 2
Health Services Research 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
NA 31
United States 20
France 8
Belgium 3
China 3
Italy 2
Germany 1
Hong Kong 1
Netherlands 1
Taiwan 1
Ukraine 1
United States|Australia|Canada|Thailand 1
United States|Canada 1
United States|Canada|Germany|United Kingdom 1
United States|Germany|Italy 1

Sites per Study

Site_count Study_Count
1 64
2 2
3 2
4 1
5 3
10 1
11 1
20 1
30 1

Enrollment Metrics

Measure Observational
Min 8.00
1st Qu 94.25
Median 248.00
Mean 2024746.66
3rd Qu 2000.00
Max 99999999.00

Observation Model

observational_model Study_Count
NA 31
Cohort 29
Case-Only 7
Case-Control 3
Other 3
Case Control 2
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 32
NA 28
Retrospective 10
Cross-Sectional 6

Registries

Studies by Country

Country Study_Count
Brazil 1
Italy 1
Korea, Republic of 1
Russian Federation 1
United States 1

Sites per Study

Site_count Study_Count
1 3
7 1
39 1

Enrollment Metrics

Measure Registries
Min 200.0
1st Qu 500.0
Median 1500.0
Mean 1150.8
3rd Qu 1716.0
Max 1838.0

Registry Model

observational_model Study_Count
Cohort 4
Other 1

Time Perspective

time_perspective Study_Count
Prospective 3
Other 2

Follow-up

target_duration Study_Count
5 Years 2
10 Years 1
2 Years 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03578367 Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) https://ClinicalTrials.gov/show/NCT03578367 Recruiting Novartis 2021-11-23
NCT03394755 Thrombosomes® in Bleeding Thrombocytopenic Patients https://ClinicalTrials.gov/show/NCT03394755 Active, not recruiting Cellphire, Inc. 2019-08-03
NCT03367546 Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases https://ClinicalTrials.gov/show/NCT03367546 Recruiting Masonic Cancer Center, University of Minnesota 2025-11-30
NCT03870750 Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases https://ClinicalTrials.gov/show/NCT03870750 Recruiting Fred Hutchinson Cancer Research Center 2024-06-30
NCT03355742 XIENCE 28 Global Study https://ClinicalTrials.gov/show/NCT03355742 Completed Abbott Medical Devices 2019-10-24
NCT03343834 Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT03343834 Recruiting Assistance Publique - Hôpitaux de Paris 2020-01-31
NCT03342495 Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial https://ClinicalTrials.gov/show/NCT03342495 Recruiting University of Calgary 2019-12-31
NCT03272789 Onco-coaching of Sport-inspired for the Social, Professional and Psychological Restoring of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells https://ClinicalTrials.gov/show/NCT03272789 Recruiting Institut Paoli-Calmettes 2019-07-31
NCT03093844 Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders https://ClinicalTrials.gov/show/NCT03093844 Active, not recruiting University of Colorado, Denver 2022-02-10
NCT03079089 Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders https://ClinicalTrials.gov/show/NCT03079089 Recruiting Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 2020-06-15
NCT03066648 Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS https://ClinicalTrials.gov/show/NCT03066648 Recruiting Novartis 2021-11-01
NCT03048344 A Phase I, Two-part Study to Determine the Recommended Dose and Evaluate the Safety and Tolerability of a Novel Oral Arsenic Trioxide Formulation (ORH-2014) in Subjects With Advanced Hematological Disorders https://ClinicalTrials.gov/show/NCT03048344 Completed Orsenix LLC 2019-02-28
NCT03030248 Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients https://ClinicalTrials.gov/show/NCT03030248 Recruiting Medical College of Wisconsin 2020-06-30
NCT03016806 Umbilical Cord Blood Transplantation From Unrelated Donors https://ClinicalTrials.gov/show/NCT03016806 Recruiting University of Rochester 2025-06-30
NCT03013439 Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) https://ClinicalTrials.gov/show/NCT03013439 Completed Pharmacosmos A/S 2017-06-04
NCT03004261 CMV-CTL for the Treatment of CMV Infection After HSCT https://ClinicalTrials.gov/show/NCT03004261 Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 2020-12-31
NCT02882776 Daily Ginger Drinking and Platelet Function https://ClinicalTrials.gov/show/NCT02882776 Completed King Abdullah International Medical Research Center 2016-07-31
NCT02722668 UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep https://ClinicalTrials.gov/show/NCT02722668 Recruiting Masonic Cancer Center, University of Minnesota 2028-05-31
NCT02678910 Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment https://ClinicalTrials.gov/show/NCT02678910 Recruiting University of Kentucky 2021-01-31
NCT02661035 Allo HSCT Using RIC for Hematological Diseases https://ClinicalTrials.gov/show/NCT02661035 Recruiting Masonic Cancer Center, University of Minnesota 2023-03-31
NCT02660281 URMC Related Haplo-identical Donor BMT https://ClinicalTrials.gov/show/NCT02660281 Recruiting University of Rochester 2025-10-31
NCT01524536 Steroid Treatment for Hypereosinophilic Syndrome https://ClinicalTrials.gov/show/NCT01524536 Recruiting National Institutes of Health Clinical Center (CC) 2024-12-31
NCT02494258 A Study to Evaluate Long-term Safety in Subjects With Solid Tumors and Hematological Disorders. https://ClinicalTrials.gov/show/NCT02494258 Active, not recruiting Celgene 2021-02-28
NCT02487563 Prospective Study of Patients With Thrombocytopenia Following HSCT https://ClinicalTrials.gov/show/NCT02487563 Completed The First Affiliated Hospital of Soochow University 2019-04-12
NCT02484053 Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders https://ClinicalTrials.gov/show/NCT02484053 Completed Baylor College of Medicine 2017-01-31
NCT02483325 Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood Diseases https://ClinicalTrials.gov/show/NCT02483325 Completed Institut Paoli-Calmettes 2018-03-31
NCT02447237 Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients https://ClinicalTrials.gov/show/NCT02447237 Completed University of Copenhagen 2015-07-31
NCT02435316 Comparison of Educational Methods for Teaching Peripheral Blood Smears https://ClinicalTrials.gov/show/NCT02435316 Completed The Reading Hospital and Medical Center 2012-06-30
NCT02343965 The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitalized in a Protective Environment, a Randomized, Controlled Study https://ClinicalTrials.gov/show/NCT02343965 Completed Nantes University Hospital 2015-12-31
NCT02218151 Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2 https://ClinicalTrials.gov/show/NCT02218151 Recruiting Duke University 2021-08-31
NCT02179359 Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies https://ClinicalTrials.gov/show/NCT02179359 Recruiting Masonic Cancer Center, University of Minnesota 2020-08-31
NCT02158052 Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease https://ClinicalTrials.gov/show/NCT02158052 Recruiting Massachusetts General Hospital 2021-02-28
NCT02130882 Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome https://ClinicalTrials.gov/show/NCT02130882 Active, not recruiting National Institutes of Health Clinical Center (CC) 2022-12-31
NCT02095951 Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection https://ClinicalTrials.gov/show/NCT02095951 Completed Children’s Hospital of Michigan 2016-06-30
NCT01962636 Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases https://ClinicalTrials.gov/show/NCT01962636 Recruiting Masonic Cancer Center, University of Minnesota 2023-10-31
NCT01959100 Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01959100 Active, not recruiting Assistance Publique - Hôpitaux de Paris 2017-04-30
NCT01844765 Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. https://ClinicalTrials.gov/show/NCT01844765 Active, not recruiting Novartis 2016-06-01
NCT01790568 Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01790568 Completed University of Michigan Rogel Cancer Center 2017-01-01
NCT01787552 A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF https://ClinicalTrials.gov/show/NCT01787552 Completed Novartis 2018-04-10
NCT01670097 Dexamethasone Dyspnea Study https://ClinicalTrials.gov/show/NCT01670097 Active, not recruiting M.D. Anderson Cancer Center 2021-01-31
NCT01666080 Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) https://ClinicalTrials.gov/show/NCT01666080 Recruiting Masonic Cancer Center, University of Minnesota 2020-06-30
NCT01602952 Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI https://ClinicalTrials.gov/show/NCT01602952 Completed Il-Yang Pharm. Co., Ltd. 2012-10-31
NCT01553461 Transplants With Unlicensed Preserved Cord Blood https://ClinicalTrials.gov/show/NCT01553461 Recruiting National Institutes of Health Clinical Center (CC) 2036-10-20
NCT01511289 Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients https://ClinicalTrials.gov/show/NCT01511289 Completed Il-Yang Pharm. Co., Ltd. 2015-02-28
NCT01445561 Ultra Low Dose Interleukin-2 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01445561 Completed National Institutes of Health Clinical Center (CC) 2013-07-15
NCT01426295 Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital https://ClinicalTrials.gov/show/NCT01426295 Completed Nantes University Hospital 2013-04-30
NCT01352520 SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) https://ClinicalTrials.gov/show/NCT01352520 Active, not recruiting M.D. Anderson Cancer Center 2021-01-31
NCT01344681 Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases https://ClinicalTrials.gov/show/NCT01344681 Completed Yonsei University 2014-03-31
NCT04353986 PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders https://ClinicalTrials.gov/show/NCT04353986 Recruiting Ain Shams University 2020-04-30
NCT04310592 Natural Killer Cell (CYNK-001) Infusions in Adults With AML https://ClinicalTrials.gov/show/NCT04310592 Recruiting Celularity Incorporated 2022-01-03
NCT04309084 Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma https://ClinicalTrials.gov/show/NCT04309084 Recruiting Celularity Incorporated 2023-03-12
NCT04249830 Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults https://ClinicalTrials.gov/show/NCT04249830 Recruiting Stanford University 2025-02-28
NCT04208243 Creative Arts Therapy (CAT) in the Center for Cancer and Blood Disorders https://ClinicalTrials.gov/show/NCT04208243 Recruiting University of Colorado, Denver 2021-02-28
NCT04202094 Evaluation of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before a Treatment Possibly Leading to Later Fertility Problems. https://ClinicalTrials.gov/show/NCT04202094 Recruiting Universitair Ziekenhuis Brussel 2022-12-31
NCT04180059 Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT04180059 Recruiting Nantes University Hospital 2022-09-30
NCT04168983 Impact of Sophrology on the Pain Felt During a Bone Marrow Aspiration and Biopsy https://ClinicalTrials.gov/show/NCT04168983 Recruiting University Hospital, Caen 2021-09-25
NCT04062266 Azacitidine and Venetoclax in Treating Patients With High Risk Acute Myeloid Leukemia in Remission https://ClinicalTrials.gov/show/NCT04062266 Recruiting M.D. Anderson Cancer Center 2030-10-31
NCT04039100 Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease https://ClinicalTrials.gov/show/NCT04039100 Recruiting Rigshospitalet, Denmark 2021-02-01
NCT03959007 Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases https://ClinicalTrials.gov/show/NCT03959007 Recruiting University Hospital, Lille 2021-09-30
NCT03918343 Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT03918343 Recruiting Centre Hospitalier Universitaire de Besancon 2021-11-30
NCT03895918 Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer Patients https://ClinicalTrials.gov/show/NCT03895918 Recruiting Roswell Park Cancer Institute 2020-07-27
NCT03875352 The Influence of Nursing Technique Applied at the Central Venous Catheter Insertion Site Upon the Incidence of Infection https://ClinicalTrials.gov/show/NCT03875352 Completed University Hospital Ostrava 2018-12-31
NCT03842696 Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation https://ClinicalTrials.gov/show/NCT03842696 Recruiting University of Michigan Rogel Cancer Center 2024-02-29
NCT03815175 XIENCE 28 USA Study https://ClinicalTrials.gov/show/NCT03815175 Active, not recruiting Abbott Medical Devices 2020-12-31
NCT03803696 Multimodal Sexual Dysfunction Intervention In HCT https://ClinicalTrials.gov/show/NCT03803696 Recruiting Massachusetts General Hospital 2024-01-01
NCT03778606 Oligosaccharide for Cdiff(+) Heme-onc Patients https://ClinicalTrials.gov/show/NCT03778606 Recruiting Medical College of Wisconsin 2020-06-01
NCT03745287 A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease https://ClinicalTrials.gov/show/NCT03745287 Recruiting Vertex Pharmaceuticals Incorporated 2021-02-28
NCT03735992 Mind-body Medicine for Patients With Malignant Hematological Diseases https://ClinicalTrials.gov/show/NCT03735992 Recruiting Universität Duisburg-Essen 2020-12-30
NCT03734588 Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors https://ClinicalTrials.gov/show/NCT03734588 Active, not recruiting Spark Therapeutics 2020-05-31
NCT03719534 Haplo SCT vs Haplo-cord SCT for Patients With Hematological Disorders https://ClinicalTrials.gov/show/NCT03719534 Recruiting The First Affiliated Hospital of Soochow University 2020-12-31
NCT03655678 A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia https://ClinicalTrials.gov/show/NCT03655678 Recruiting Vertex Pharmaceuticals Incorporated 2021-02-28
NCT03615144 TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors https://ClinicalTrials.gov/show/NCT03615144 Recruiting Memorial Sloan Kettering Cancer Center 2021-07-31
NCT03611257 Effect of dRAST on Treatment for Bacteremia in Patients With Hematologic Diseases https://ClinicalTrials.gov/show/NCT03611257 Completed Seoul National University Hospital 2019-09-15
NCT03548766 Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping https://ClinicalTrials.gov/show/NCT03548766 Recruiting Hamad Medical Corporation 2019-12-31
NCT03520712 Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5 https://ClinicalTrials.gov/show/NCT03520712 Enrolling by invitation BioMarin Pharmaceutical 2025-06-30
NCT03518294 NASH Fitness Intervention in Thrombosis Trial (NASHFit) https://ClinicalTrials.gov/show/NCT03518294 Recruiting Milton S. Hershey Medical Center 2021-06-01
NCT03426553 Clinical Use of Pathogen Reduced Red Blood Cell Suspension https://ClinicalTrials.gov/show/NCT03426553 Completed Federal Research Institute of Pediatric Hematology, Oncology and Immunology 2018-09-17
NCT01224496 Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders https://ClinicalTrials.gov/show/NCT01224496 Completed Singapore General Hospital 2011-08-31
NCT01220011 Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery https://ClinicalTrials.gov/show/NCT01220011 Active, not recruiting Assistance Publique - Hôpitaux de Paris 2018-09-30
NCT01210716 Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device https://ClinicalTrials.gov/show/NCT01210716 Completed Fenwal, Inc. 2011-05-31
NCT00994136 Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters https://ClinicalTrials.gov/show/NCT00994136 Completed Universitaire Ziekenhuizen Leuven 2011-06-30
NCT00993486 Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor https://ClinicalTrials.gov/show/NCT00993486 Completed Kiadis Pharma 2008-10-31
NCT00954941 Ondansetron Versus Aprepitant Plus Ondansetron for Emesis https://ClinicalTrials.gov/show/NCT00954941 Completed M.D. Anderson Cancer Center 2013-04-30
NCT00919503 Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders https://ClinicalTrials.gov/show/NCT00919503 Recruiting Fred Hutchinson Cancer Research Center 2023-02-01
NCT00897260 Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders https://ClinicalTrials.gov/show/NCT00897260 Completed University of British Columbia 2013-01-09
NCT00892502 Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? https://ClinicalTrials.gov/show/NCT00892502 Completed Copenhagen University Hospital at Herlev 2012-01-31
NCT03886909 Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT03886909 Recruiting Milton S. Hershey Medical Center 2021-05-31
NCT01974401 Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia https://ClinicalTrials.gov/show/NCT01974401 Completed Mashhad University of Medical Sciences 2011-03-31
NCT03547609 Assessment of Memory in Children With Kabuki Syndrom https://ClinicalTrials.gov/show/NCT03547609 Completed University Hospital, Montpellier 2018-09-07
NCT02632708 Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation https://ClinicalTrials.gov/show/NCT02632708 Active, not recruiting Agios Pharmaceuticals, Inc. 2018-12-13
NCT00800839 Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide https://ClinicalTrials.gov/show/NCT00800839 Completed M.D. Anderson Cancer Center 2015-07-31
NCT00636909 Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders https://ClinicalTrials.gov/show/NCT00636909 Completed Beth Israel Deaconess Medical Center 2006-03-31
NCT00616460 ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding https://ClinicalTrials.gov/show/NCT00616460 Completed HaEmek Medical Center, Israel 2011-10-31
NCT00586521 BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) https://ClinicalTrials.gov/show/NCT00586521 Completed Bayer 2008-03-31
NCT00582894 Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases https://ClinicalTrials.gov/show/NCT00582894 Completed University of Oklahoma 2008-03-31
NCT00533923 Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders https://ClinicalTrials.gov/show/NCT00533923 Completed Beth Israel Deaconess Medical Center 2007-01-31
NCT00507533 Early Application of CPAP in Hematologic https://ClinicalTrials.gov/show/NCT00507533 Completed University of Turin, Italy 2007-11-30
NCT00484848 Functional Evaluation of Two Types of Totally Implanted Venous Ports https://ClinicalTrials.gov/show/NCT00484848 Completed Universitaire Ziekenhuizen Leuven 2004-12-31
NCT00309842 Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases https://ClinicalTrials.gov/show/NCT00309842 Completed Masonic Cancer Center, University of Minnesota 2019-07-29
NCT00231309 Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT) https://ClinicalTrials.gov/show/NCT00231309 Completed Emory University 2011-11-30
NCT00213239 A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children https://ClinicalTrials.gov/show/NCT00213239 Completed The Hospital for Sick Children 2007-09-30
NCT00208962 Allogeneic Cell Therapy for Adults With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00208962 Completed Emory University 2007-09-30
NCT00168090 Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) https://ClinicalTrials.gov/show/NCT00168090 Completed CSL Behring NA
NCT00137787 Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases https://ClinicalTrials.gov/show/NCT00137787 Completed Center for Supporting Hematology-Oncology Trials 2009-12-31
NCT00113893 SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes. https://ClinicalTrials.gov/show/NCT00113893 Completed Scios, Inc. 2007-12-31
NCT00111215 Treatment and Management of Women With Bleeding Disorders https://ClinicalTrials.gov/show/NCT00111215 Completed Centers for Disease Control and Prevention NA
NCT01114165 Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients https://ClinicalTrials.gov/show/NCT01114165 Completed University Hospital Muenster 2012-09-30
NCT00071032 Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease https://ClinicalTrials.gov/show/NCT00071032 Completed Rutgers, The State University of New Jersey 2009-05-31
NCT00056966 Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases https://ClinicalTrials.gov/show/NCT00056966 Completed Baylor College of Medicine 2005-05-31
NCT00001839 A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00001839 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001338 A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer https://ClinicalTrials.gov/show/NCT00001338 Completed National Institutes of Health Clinical Center (CC) NA
NCT00029393 Induction of Stable Chimerism for Sickle Cell Anemia https://ClinicalTrials.gov/show/NCT00029393 Completed National Heart, Lung, and Blood Institute (NHLBI) 2007-07-31
NCT00029380 Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia https://ClinicalTrials.gov/show/NCT00029380 Completed National Heart, Lung, and Blood Institute (NHLBI) 2006-08-31
NCT00023530 Blood and Marrow Transplant Clinical Research Network https://ClinicalTrials.gov/show/NCT00023530 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00820508 Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies https://ClinicalTrials.gov/show/NCT00820508 Completed Chroma Therapeutics 2011-07-31
NCT00006400 Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia https://ClinicalTrials.gov/show/NCT00006400 Completed National Heart, Lung, and Blood Institute (NHLBI) 2009-09-30
NCT00006182 Stroke Prevention in Sickle Cell Anemia (STOP 2) https://ClinicalTrials.gov/show/NCT00006182 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00001749 Medical Treatment for Diamond Blackfan Anemia https://ClinicalTrials.gov/show/NCT00001749 Completed National Institutes of Health Clinical Center (CC) NA
NCT00000603 Cord Blood Stem Cell Transplantation Study (COBLT) https://ClinicalTrials.gov/show/NCT00000603 Completed National Heart, Lung, and Blood Institute (NHLBI) 2007-10-31
NCT00000602 Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG) https://ClinicalTrials.gov/show/NCT00000602 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00000597 Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders https://ClinicalTrials.gov/show/NCT00000597 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00000595 Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis https://ClinicalTrials.gov/show/NCT00000595 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00000592 Stroke Prevention in Sickle Cell Anemia (STOP 1) https://ClinicalTrials.gov/show/NCT00000592 Completed Augusta University NA
NCT00000589 Trial to Reduce Alloimmunization to Platelets (TRAP) https://ClinicalTrials.gov/show/NCT00000589 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00000588 Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone https://ClinicalTrials.gov/show/NCT00000588 Completed Case Western Reserve University NA
NCT00000587 Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection https://ClinicalTrials.gov/show/NCT00000587 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00000586 Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH) https://ClinicalTrials.gov/show/NCT00000586 Completed National Heart, Lung, and Blood Institute (NHLBI) 1994-06-30
NCT00000585 Penicillin Prophylaxis in Sickle Cell Disease (PROPS) https://ClinicalTrials.gov/show/NCT00000585 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00000582 Cooperative Study of Factor VIII Inhibitors https://ClinicalTrials.gov/show/NCT00000582 Completed National Heart, Lung, and Blood Institute (NHLBI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04450927 Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors https://ClinicalTrials.gov/show/NCT04450927 Recruiting National Institutes of Health Clinical Center (CC) 2030-03-31
NCT00059423 Natural History Study for BEN https://ClinicalTrials.gov/show/NCT00059423 Completed National Institutes of Health Clinical Center (CC) 2019-04-23
NCT03313583 French One Day Survey in 2011 - Knowing Our Population of Labile Blood Products Recipients https://ClinicalTrials.gov/show/NCT03313583 Completed Etablissement Français du Sang 2011-11-01
NCT03299608 Rapid Analysis of Infections by Spectrometry of Exhaled Breath https://ClinicalTrials.gov/show/NCT03299608 Recruiting Universitaire Ziekenhuizen Leuven 2021-06-30
NCT03250845 Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder https://ClinicalTrials.gov/show/NCT03250845 Completed Universitaire Ziekenhuizen Leuven 2017-10-31
NCT03207854 Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers https://ClinicalTrials.gov/show/NCT03207854 Recruiting University of Southern California 2022-04-12
NCT02918695 Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients https://ClinicalTrials.gov/show/NCT02918695 Recruiting Universitaire Ziekenhuizen Leuven 2019-12-31
NCT02108444 Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients https://ClinicalTrials.gov/show/NCT02108444 Completed Peking University 2013-12-31
NCT00695123 Screening for Subjects to Participate in Studies of Blood Disorders https://ClinicalTrials.gov/show/NCT00695123 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02442011 Hematology Biobank : Invitro Study of Blood Disorders https://ClinicalTrials.gov/show/NCT02442011 Recruiting Albert Einstein College of Medicine 2025-12-31
NCT02329808 Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics https://ClinicalTrials.gov/show/NCT02329808 Recruiting Radboud University 2020-12-31
NCT02090803 Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells https://ClinicalTrials.gov/show/NCT02090803 Completed Institut de Cancérologie de la Loire 2015-03-31
NCT01314534 French Kabuki Syndrome Network. Epidemiology, Management of Patients and Research by Array-CGH https://ClinicalTrials.gov/show/NCT01314534 Completed Assistance Publique - Hôpitaux de Paris 2015-03-31
NCT01287000 Gulf Long-Term Follow-Up Study https://ClinicalTrials.gov/show/NCT01287000 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT02057185 Occupational Status and Hematological Disease https://ClinicalTrials.gov/show/NCT02057185 Active, not recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2019-03-31
NCT01737554 Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents https://ClinicalTrials.gov/show/NCT01737554 Completed St. Jude Children’s Research Hospital 2016-09-30
NCT04386928 ALLO-SCT in Elderly Patients With Hematological Disease https://ClinicalTrials.gov/show/NCT04386928 Recruiting Gruppo Italiano Trapianto di Midollo Osseo 2021-02-28
NCT04279470 Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events https://ClinicalTrials.gov/show/NCT04279470 Active, not recruiting Groupe Hospitalier Pitie-Salpetriere 2025-01-01
NCT04208529 A Long-term Follow-up Study in Subjects Who Received CTX001 https://ClinicalTrials.gov/show/NCT04208529 Enrolling by invitation Vertex Pharmaceuticals Incorporated 2039-09-30
NCT03920735 Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients https://ClinicalTrials.gov/show/NCT03920735 Recruiting University Hospital, Strasbourg, France 2019-07-15
NCT03876301 Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants https://ClinicalTrials.gov/show/NCT03876301 Active, not recruiting Spark Therapeutics 2020-07-31
NCT03868527 The ARCAN Database is Used for Retrospective Non-interventional Research Projects. The Database Collects Clinical and Laboratory Data From Patients With Lymphoid Malignancies. The Database Doesn’t Require Biological Sample of Patients, it Records Only Information Based on the Patients’ Medical File. https://ClinicalTrials.gov/show/NCT03868527 Recruiting Hospices Civils de Lyon 2025-12-31
NCT03854318 Longitudinal Studies of Patient With FPDMM https://ClinicalTrials.gov/show/NCT03854318 Recruiting National Institutes of Health Clinical Center (CC) 2028-12-31
NCT03848962 Collection and Distribution of Biospecimens for Novel Research Uses https://ClinicalTrials.gov/show/NCT03848962 Recruiting iSpecimen Inc 2025-12-31
NCT03586180 Medical Clowning: Needs Assessment and Implication for Hospitalized Children With Cancer/Blood Disease https://ClinicalTrials.gov/show/NCT03586180 Recruiting National Taiwan University Hospital 2021-03-31
NCT03540654 Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach https://ClinicalTrials.gov/show/NCT03540654 Completed University Hospital, Bordeaux 2018-10-31
NCT03535220 The American Society of Hematology (ASH) Research Registry: A Multicenter Research Registry of Patients With Hematologic Disease https://ClinicalTrials.gov/show/NCT03535220 Active, not recruiting American Society of Hematology 2023-12-31
NCT03488641 Systematic and Mechanism-based Approach to Rational Treatment Trials of Blood Cancer https://ClinicalTrials.gov/show/NCT03488641 Recruiting German Cancer Research Center 2021-07-31
NCT01254318 Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501) https://ClinicalTrials.gov/show/NCT01254318 Completed Merck Sharp & Dohme Corp. 2014-11-30
NCT01178177 Radiologic Features of Invasive Pulmonary Aspergillosis https://ClinicalTrials.gov/show/NCT01178177 Completed Asan Medical Center 2010-02-28
NCT01108159 Integrated Whole-Genome Analysis of Hematologic Disorders https://ClinicalTrials.gov/show/NCT01108159 Completed Stanford University 2013-08-02
NCT00956358 Study on Systemic and Airway Biomarkers in Haemopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00956358 Completed The University of Hong Kong 2015-12-31
NCT00909207 Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing https://ClinicalTrials.gov/show/NCT00909207 Completed M.D. Anderson Cancer Center 2013-06-30
NCT03855631 Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders https://ClinicalTrials.gov/show/NCT03855631 Active, not recruiting University Hospital, Montpellier 2019-10-30
NCT00782470 Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A https://ClinicalTrials.gov/show/NCT00782470 Completed Bayer 2010-11-30
NCT00675038 Pilot Study of Non-Invasive Assessment of Hepatic And Myocardial Iron Through T2* Magnet Resonance Imaging (MRI) In Patients With Iron Overload https://ClinicalTrials.gov/show/NCT00675038 Completed St. Jude Children’s Research Hospital 2007-06-30
NCT00561639 Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting Sepsis https://ClinicalTrials.gov/show/NCT00561639 Completed University Hospital, Grenoble NA
NCT00390988 Capillary and Venous Blood Count Parameters https://ClinicalTrials.gov/show/NCT00390988 Completed University of Magdeburg NA
NCT00365014 Progression of Hematopoietic Diseases in Shanghai, China https://ClinicalTrials.gov/show/NCT00365014 Completed University of Colorado, Denver 2009-12-31
NCT00364520 Molecular Epidemiology of Benzene-exposed Workers. https://ClinicalTrials.gov/show/NCT00364520 Completed University of Colorado, Denver 2009-12-31
NCT00341016 Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident https://ClinicalTrials.gov/show/NCT00341016 Completed National Institutes of Health Clinical Center (CC) 2020-02-12
NCT00223483 Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers https://ClinicalTrials.gov/show/NCT00223483 Active, not recruiting The University of Texas Health Science Center at San Antonio 2020-12-31
NCT00186147 Bone Marrow Grafting for Leukemia and Lymphoma https://ClinicalTrials.gov/show/NCT00186147 Enrolling by invitation Stanford University 2069-12-31
NCT00179946 HLA Matching - Unrelated Umbilical Cord Blood Transplantation https://ClinicalTrials.gov/show/NCT00179946 Completed Ann & Robert H Lurie Children’s Hospital of Chicago 2006-04-30
NCT00106015 Diamond Blackfan Anemia Registry (DBAR) https://ClinicalTrials.gov/show/NCT00106015 Recruiting Northwell Health 2021-04-30
NCT00059293 Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG https://ClinicalTrials.gov/show/NCT00059293 Completed National Heart, Lung, and Blood Institute (NHLBI) 2008-07-31
NCT00037388 Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II https://ClinicalTrials.gov/show/NCT00037388 Completed National Heart, Lung, and Blood Institute (NHLBI) 2006-06-30
NCT00035763 Pain in Sickle Cell Epidemiologic Study https://ClinicalTrials.gov/show/NCT00035763 Completed Virginia Commonwealth University 2006-08-31
NCT00007371 Hepatitis C in Clinically Discordant Hemophilic Siblings https://ClinicalTrials.gov/show/NCT00007371 Completed University of North Carolina, Chapel Hill 2004-08-31
NCT00006314 Cytomegalovirus Spread and Reactivation in Blood Cells https://ClinicalTrials.gov/show/NCT00006314 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00006312 Hemochromatosis–Genetic Prevalence and Penetrance https://ClinicalTrials.gov/show/NCT00006312 Completed University of Rochester NA
NCT00005703 Hemostasis in Sickle Cell Disease–Infancy to Adulthood https://ClinicalTrials.gov/show/NCT00005703 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005682 Aplastic Anemia Epidemiology: Incidence and Case-control https://ClinicalTrials.gov/show/NCT00005682 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005559 Statistical Basis for Hemochromatosis Screening https://ClinicalTrials.gov/show/NCT00005559 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005556 Retention of Bone Marrow Donors in a National Registry https://ClinicalTrials.gov/show/NCT00005556 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005541 Hemochromatosis and Iron Overload Screening Study (HEIRS) https://ClinicalTrials.gov/show/NCT00005541 Completed National Heart, Lung, and Blood Institute (NHLBI) 2006-01-31
NCT00005518 Epidemiology and Immunology of Hemophilia A Inhibitors https://ClinicalTrials.gov/show/NCT00005518 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005467 Indices of Severity and Prognosis for Sickle Cell Disease https://ClinicalTrials.gov/show/NCT00005467 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005438 Neuropsychological Studies of Children With Sickle Cell https://ClinicalTrials.gov/show/NCT00005438 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005341 Blood Donation–Immune Sequelae and Recruitment https://ClinicalTrials.gov/show/NCT00005341 Completed University of New Mexico NA
NCT00005327 Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center https://ClinicalTrials.gov/show/NCT00005327 Completed University of Southern California 1998-03-31
NCT00005326 Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center https://ClinicalTrials.gov/show/NCT00005326 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005309 Prospective Study of HIV Infection in Hemophiliacs https://ClinicalTrials.gov/show/NCT00005309 Completed Bloodworks 1995-03-31
NCT00005308 Anemia and Surgery: Indications For Transfusion https://ClinicalTrials.gov/show/NCT00005308 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005307 Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data https://ClinicalTrials.gov/show/NCT00005307 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005305 Hepatitis Delta Infections in Hemophiliacs https://ClinicalTrials.gov/show/NCT00005305 Completed University of North Carolina, Chapel Hill 1991-09-30
NCT00005304 Delta Hepatitis and Liver Disease in Hemophiliacs https://ClinicalTrials.gov/show/NCT00005304 Completed Baylor College of Medicine NA
NCT00005302 Drug Etiology of Aplastic Anemia and Related Dyscrasias https://ClinicalTrials.gov/show/NCT00005302 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005300 Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease https://ClinicalTrials.gov/show/NCT00005300 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005277 Cooperative Study of The Clinical Course of Sickle Cell Disease https://ClinicalTrials.gov/show/NCT00005277 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005154 National Health and Nutrition Examination Survey IV (NHANES (IV) https://ClinicalTrials.gov/show/NCT00005154 Completed National Heart, Lung, and Blood Institute (NHLBI) 2008-12-31
NCT00005126 Vietnam Era Twin (VET) Registry https://ClinicalTrials.gov/show/NCT00005126 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00001715 Evaluation of Patients With Blood Disorders https://ClinicalTrials.gov/show/NCT00001715 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001620 Screening for Hematology Branch Protocols https://ClinicalTrials.gov/show/NCT00001620 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00001397 Evaluation, Treatment, and Training for Patients With Blood Disorders https://ClinicalTrials.gov/show/NCT00001397 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00000623 Thalassemia (Cooley’s Anemia) Clinical Research Network (TCRN) https://ClinicalTrials.gov/show/NCT00000623 Completed HealthCore-NERI NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02827149 High Resolution Donor Recipient HLA Matching Level in Unrelated HSCT https://ClinicalTrials.gov/show/NCT02827149 Completed Gruppo Italiano Trapianto di Midollo Osseo 2018-09-01
NCT02720679 Investigation of the Genetics of Hematologic Diseases https://ClinicalTrials.gov/show/NCT02720679 Recruiting St. Jude Children’s Research Hospital 2026-08-31
NCT02380378 Registry of Philadelphia-Negative Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT02380378 Recruiting Hospital Israelita Albert Einstein 2022-12-31
NCT02330718 Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia https://ClinicalTrials.gov/show/NCT02330718 Recruiting Yonsei University 2019-12-31
NCT04422470 Registry of Patients With Hematologic Disease and COVID-19 in Russia https://ClinicalTrials.gov/show/NCT04422470 Recruiting National Research Center for Hematology, Russia 2021-01-22